Clinical Trials

Can This $2.1 Billion Deal Advance Breakthrough Treatments in Immunology?
Research & Development Can This $2.1 Billion Deal Advance Breakthrough Treatments in Immunology?

In a significant development, Monte Rosa Therapeutics, a biotechnology company based in Boston, has finalized a highly lucrative global exclusive development and commercialization license agreement with Novartis valued at up to $2.1 billion on October 28, 2024. Monte Rosa Therapeutics is focused on

Can LakeShore Biopharma Sustain Growth After Regaining Nasdaq Compliance?
Management & Regulatory Can LakeShore Biopharma Sustain Growth After Regaining Nasdaq Compliance?

LakeShore Biopharma Co., Ltd (NASDAQ: LSB), a prominent biopharmaceutical company, has successfully regained compliance with Nasdaq's minimum bid price requirement after experiencing non-compliance due to a prolonged period of its share price falling below $1.00. As of October 21, 2024, the

How Will AI Transform Drug Discovery and Development in Biopharma?
Research & Development How Will AI Transform Drug Discovery and Development in Biopharma?

Artificial Intelligence (AI) has the potential to revolutionize drug discovery and development, offering numerous advantages that could transform current practices in the biopharmaceutical industry. By merging Accenture's advanced capabilities in AI scaling with the innovative ITO™ platform d

New Long-Lasting Malaria Injectable Enters Phase 1 Clinical Trials
Research & Development New Long-Lasting Malaria Injectable Enters Phase 1 Clinical Trials

In a remarkable advancement in the fight against malaria, The Medicines for Malaria Venture (MMV) and Quotient Sciences have initiated a Phase 1 clinical trial for MMV371, a long-acting injectable (LAI) malaria preventive. Conducted with healthy volunteers in Nottingham, UK, this trial represents a

How Is Switzerland Leading Innovation in the Biotech Industry?
Biotech & Bioprocessing How Is Switzerland Leading Innovation in the Biotech Industry?

Switzerland has established itself as a global leader in the biotech industry, making significant advancements in areas such as cancer treatment, immunotherapy, gene and cell therapy, and more. With a strong focus on personalized and precision medicine, the Swiss biotech sector thrives on

Enhancing Clinical Trials: Patient-Centricity and Decentralization Innovations
Research & Development Enhancing Clinical Trials: Patient-Centricity and Decentralization Innovations

Clinical trials have long faced significant challenges in enrolling and retaining participants, a problem exacerbated by logistical and engagement difficulties inherent in the clinical trial process. Recent data highlights that up to one-third of trial participants drop out before the studies are

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later